Prostate cancer supp "may cut risk 55%"

13 August 2006

According to Premiere Enterprises, a distributor of the dietary supplement Prostate Health Cocktail, research conducted at the USA's Harvard University's School of Public Health indicates men may cut their risk of prostate cancer in half, simply by taking a combination of natural ingredients. The landmark study of more than 2,000 men found those with the highest level of vitamin D in their blood had a 55% lower risk for prostate cancer.

Scientists across the USA and Europe have found similar benefits linked to other natural substances. Taken together, the data suggest that a combination of particular minerals, herbs, vitamins and isoflavanoids (including green tea, lycopene and genistein) can reduce the risk of developing prostate cancer and improve outcomes for men with the disease, Premier Enterprises noted.

One in six American men will be diagnosed with prostate cancer, which accounts for 30% of all cancers diagnosed in the USA. The condition kills more than 30,000 US males annually, making it the second leading cause of cancer death in men.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight